Advertisement
Research Article

Enhanced Protective Efficacy of a Chimeric Form of the Schistosomiasis Vaccine Antigen Sm-TSP-2

  • Mark S. Pearson,

    Affiliation: Queensland Tropical Health Alliance and School of Public Health and Tropical Medicine, James Cook University, Cairns, Queensland, Australia

    X
  • Darren A. Pickering,

    Affiliation: Queensland Tropical Health Alliance and School of Public Health and Tropical Medicine, James Cook University, Cairns, Queensland, Australia

    X
  • Henry J. McSorley,

    Affiliation: Queensland Tropical Health Alliance and School of Public Health and Tropical Medicine, James Cook University, Cairns, Queensland, Australia

    X
  • Jeffrey M. Bethony,

    Affiliation: Department of Microbiology, Immunology and Tropical Medicine, George Washington University, Washington D.C., United States of America

    X
  • Leon Tribolet,

    Affiliation: Queensland Tropical Health Alliance and School of Public Health and Tropical Medicine, James Cook University, Cairns, Queensland, Australia

    X
  • Annette M. Dougall,

    Affiliation: Queensland Tropical Health Alliance and School of Public Health and Tropical Medicine, James Cook University, Cairns, Queensland, Australia

    X
  • Peter J. Hotez,

    Affiliation: Department of Pediatrics and Molecular Virology and Microbiology, and National School of Tropical Medicine, Sabin Vaccine Institute and Texas Children's Hospital Center for Vaccine Development, Baylor College of Medicine, Houston, Texas, United States of America

    X
  • Alex Loukas mail

    alex.loukas@jcu.edu.au

    Affiliation: Queensland Tropical Health Alliance and School of Public Health and Tropical Medicine, James Cook University, Cairns, Queensland, Australia

    X
  • Published: March 13, 2012
  • DOI: 10.1371/journal.pntd.0001564

Media Coverage of this Article

Found additional news media or blog coverage for the article? Please let us know.